• Explore /
  • Poster
  • / Final analysis of multi-histology basket trial expansion of ado-trastuzumab emtansine in patients with <em>HER2</em> amplified cancers.

Final analysis of multi-histology basket trial expansion of ado-trastuzumab emtansine in patients with HER2 amplified cancers.

Abstract Poster

Authors

null

Dazhi Liu

Memorial Sloan Kettering Cancer Center, New York, NY

Dazhi Liu , Vicky Makker , Darren J. Buonocore , Ronglai Shen , Rona Yaeger , Michelle S. Ginsberg , Randy Yeh , Amanda Johnson , Michael Offin , David B. Solit , Alexander E. Drilon , Charles M. Rudin , Mark G. Kris , Jorge S. Reis-Filho , Pedram Razavi , Sarat Chandarlapaty , Kanika Arora , Michael F. Berger , Alan Loh Ho , Bob T. Li

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

Chemotherapy and Antibody-Drug Conjugates

Clinical Trial Registration Number

NCT02675829

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 3025)

DOI

10.1200/JCO.2023.41.16_suppl.3025

Abstract #

3025

Poster Bd #

223

Abstract Disclosures

Funded by Conquer Cancer

Similar Posters

First Author: Sherry Shen

First Author: Sadakatsu Ikeda

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Comprehensive clinico-molecular profile and efficacy of anti-HER2 therapy for <em>HER2</em>-amplified biliary tract cancer.

Comprehensive clinico-molecular profile and efficacy of anti-HER2 therapy for HER2-amplified biliary tract cancer.

First Author: Kanae Inoue

First Author: Alessandro Santin